Comparison of requirements for using health claims on foods in the European Union, the USA, Canada, and Australia/New Zealand. Issue 2 (10th February 2021)

• Record Type: Journal Article
• Authors: Kušar, Anita; Žmitek, Katja; Lähteenmäki, Liisa; Raats, Monique M.; Pravst, Igor
• Is Part Of: Comprehensive reviews in food science and food safety. Volume 20:Issue 2(2021)
• Page Start: 1307
• Page End: 1332
• Publication Date: 2021-02-10
• Subjects: food labeling -- functional foods -- health claims -- regulation -- substantiation; Food -- Research -- Periodicals; Food -- Safety measures -- Periodicals; 664.0072
• DOI: 10.1111/1541-4337.12716
• Languages: English
• ISSNs: 1541-4337

Abstract

Abstract: Nutrition is recognized as one of the leading factors influencing the growing incidence of noncommunicable diseases. Despite society experiencing a global rise in obesity, specific populations remain at risk of nutrient deficiencies. The food industry can use health claims to inform consumers about the health benefits of foods through labeling and the broader promotion of specific food products. As health claims are carefully regulated in many countries, their use is limited due to considerable investments required to fulfill the regulatory requirement. Although health claims represent a driving force for innovation in the food industry, the risk of misleading of consumers need to be avoided. The health claim scientific substantiation process must be efficient and transparent in order to meet the needs of companies in the global market, but should be based on strong scientific evidence and plausible mechanisms of actions, to ensure highest level of consumer protection. The objective of this review is to compare the possibilities for using health claims on foods in the European Union, the USA, Canada, and Australia and New Zealand. In particular, we focused on differences in the classification of claims, on the scientific substantiation processes and requirements for health claims use on foods in the selected regions. Reduction of disease risk (RDR) claims are associated with relatively similar procedures and conditions for use, whereas several notable differences were identified for other types of claims. In all cases, RDR claims must be approved prior their introduction to the market, and only a few such claims have been authorized. Much greater differences were observed concerning other types of claims.